Primary study · included by 1 review
Identification and Validation of HOTAIRM1 as a Novel Biomarker for Oral Squamous Cell Carcinoma
Yu 2022 · Yu Yixiu, Niu Jiamei, Zhang Xingwei, et al. · Frontiers in Bioengineering and Biotechnology · 2022
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score | HR 2.24 [1.61, 3.12] | 6 studies | Moderate |
Overall survival High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score | HR 2.13 [1.56, 2.89] | 5 studies | GRADE not reported |
1 including review in total.